메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

BIOSeedin Winter Innovation Partnering Summit：J.P.Morgan Spotlight

SAN FRANCISCO, Jan. 26, 2026 -- To enable Chinese innovative pharmaceutical companies to more efficiently connect with international resources, bioSeedin, a platform facilitating cooperation in innovative drug assets, hosted the BIOSeedin Winter Innovation Partnering Summit in San Francisco on January 11, 2026. The event centered on the "China Asset Showcase", providing an exclusive international roadshow and licensing cooperation forum dedicated to Chinese innovative drugs. The summit brought together over 500 industry representatives from more than ten countries and regions
- 김갑성 기자
- 2026-01-26 22:00
Jin Medical International Ltd. To Host Management Fireside Chat

CHANGZHOU, China, Jan. 26, 2026 -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment in China, announced today that its Chief Executive Officer, together with the Company's management team, will host a fireside chat at 8:00 pm EST on February 1, 2026. The discussion will provide insights into the Company's recent strategic priorities and long-term growth considerations. The Company also announced the launch of its updated corporate
- 김갑성 기자
- 2026-01-26 21:57
Divamics Showcases Lead Autoimmune Program DVI-001 and Unveils New Metabolic Program DVI-004 at JPM Week 2026

SAN FRANCISCO, Jan. 26, 2026 -- Divamics (DIVAMICS), an AI-driven biotechnology company specializing in high-precision molecular discovery, highlighted the significant advancement of its internal pipeline during the Biotech Showcase™ at JPM Week 2026. The company provided updated milestones for its lead autoimmune program, DVI-001, and announced the first disclosure of DVI-004, a promising new metabolic disease program generated by its proprietary AI platform. The presentation centered on Divamics' ability to bridge the gap between AI-driven prediction and clinical-ready assets.
- 김갑성 기자
- 2026-01-26 20:00
Gu Sheng Tang Donates S$1.06 Million to NTU Singapore to Advance Traditional Chinese Medicine Research and Education in Singapore

SINGAPORE, Jan. 26, 2026 -- Leading Traditional Chinese Medicine (TCM) healthcare group Gu Sheng Tang TCM and Nanyang Technological University, Singapore (NTU Singapore) officially launched the Gu Sheng Tang Traditional Chinese Medicine Education and Research Programme today. As part of the programme, Gu Sheng Tang TCM has donated S$1.06 million to NTU, aimed at advancing TCM talent development and evidence-based research in Singapore, while supporting the country's broader healthcare ecosystem. The launch was formalised at a signing ceremony at PARKROYAL COLLECTION Pickering,
- 김갑성 기자
- 2026-01-26 18:00
WuXi Biologics and HanchorBio Enter Strategic Partnership to Advance Next-Generation Bi- and Multi-Functional Fusion Protein Pipeline

SHANGHAI, Jan. 26, 2026 -- WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, jointly announced today the signing of a strategic collaboration agreement on the development and manufacturing of multiple next-generation bi-/multi-functional fusion programs from HanchorBio's pipeline. Under the agreement, WuXi Biologics will provide integrated, end-to-end biolog
- 김갑성 기자
- 2026-01-26 17:35
HKUST President Prof. Nancy IP Engages in Global Dialogues at Davos 2026 on Neuroscience, University Leadership, and the Future of Research

HONG KONG, Jan. 26, 2026 -- Prof. Nancy IP, President of The Hong Kong University of Science and Technology (HKUST), joined global leaders at the World Economic Forum (WEF) Annual Meeting 2026 in Davos-Klosters, Switzerland. As the sole university president representing Hong Kong, she participated in high-level dialogues on neuroscience, the evolving role of universities, the future of global research, and health innovation. Held under the theme "A Spirit of Dialogue", this year's Annual Meeting convened over 3,000 esteemed leaders from government, business, civil society, an
- 김갑성 기자
- 2026-01-26 15:43
HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline

SHANGHAI, TAIPEI and SAN FRANCISCO, Jan. 26, 2026 -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, and WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), jointly announced today the signing of a strategic collaboration agreement to support the development and manufacturing of multiple next-generation bi- and multi-functional fusion programs from HanchorBio's pipeline. Under the agreement, WuXi Biologics wi
- 김갑성 기자
- 2026-01-26 15:00
Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel's "Poetics of Time" Brand Positioning

SHANGHAI, Jan. 26, 2026 -- Moyom Biotechnology recently announced a strategic partnership with WPP Group, one of the world's leading global communications and creative networks. The partnership is centered on the "Poetics of Time" brand framework and will focus on the long-term evolution of Aphranel's global brand communications. Headquartered in London, WPP Group operates in more than 100 countries worldwide, integrating capabilities across creative, media, public relations, digital, consulting, and artificial intelligence. Through the partnership, WPP will draw on i
- 김갑성 기자
- 2026-01-26 13:56
Get Exclusive Limited-Edition Gifts During Your Lunar New Year Trip: Wakamoto Launches "Thank You from Wakamoto" Campaign

TOKYO, Jan. 26, 2026 -- Wakamoto Pharmaceutical Co., Ltd. (Tokyo, Arata Igarashi), a company dedicated to supporting healthy and active lifestyles, will launch a nationwide campaign in which customers who purchase "Strong Wakamoto" will receive an original hand towel. The campaign will be held at drugstores and other retail outlets across Japan, welcoming visitors from the Taiwan region who celebrate the Lunar New Year in Japan. Campaign Background In 2024, Wakamoto celebrated its 95th anniversary. To express its appreciation to customers who have long s
- 김갑성 기자
- 2026-01-26 13:00
Natural Good Things Achieves Major Success with Taiwanese Artist Halo Mavis, Records 250,000 Live Commerce Sales

SEOUL, South Korea, Jan. 26, 2026 -- Women's wellness inner-care brand Natural Good Things (NGT) is making significant strides in the global market through a strategic partnership with Taiwanese artist and mega influencer Halo Mavis. NGT announced that it achieved cumulative sales of approximately 250,000 units through four live commerce collaborations conducted over the past year with top Taiwanese influencer Halo Mavis. NGT specializes in the production and distribution of health functional food ingredients and operates under the brand philosophy of "wellness inner care f
- 노기식 기자
- 2026-01-26 11:00

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2026-03-03_TUE

Innovaccer Receives Frost & Sullivan's 2026 United States New Product Innovation Recognition for Excellence in AI-Driven Patient Access Solutions 00:57

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 03일 02시 40분